David Lally to Ranibizumab
This is a "connection" page, showing publications David Lally has written about Ranibizumab.
Connection Strength
0.951
-
Lally DR, Hill L, Amador-Patarroyo MJ. Subretinal Fluid Resolution and Visual Acuity in Patients with Neovascular Age-Related Macular Degeneration: A HARBOR Post Hoc Analysis. Ophthalmol Retina. 2022 11; 6(11):1054-1060.
Score: 0.804
-
Lally DR, Gerstenblith AT, Regillo CD. Preferred therapies for neovascular age-related macular degeneration. Curr Opin Ophthalmol. 2012 May; 23(3):182-8.
Score: 0.100
-
Enr?quez AB, Baumal CR, Crane AM, Witkin AJ, Lally DR, Liang MC, Enr?quez JR, Eichenbaum DA. Early Experience With Brolucizumab Treatment of Neovascular Age-Related Macular Degeneration. JAMA Ophthalmol. 2021 Apr 01; 139(4):441-448.
Score: 0.046